$36M sweet spot round size
Most of their 7 investments are in rounds between $12M and $42M
2016
Verge Genomics raised $98M on December 16, 2021
Investors: Section 32, Lifeforce Capital, Alumni Ventures Group, Vulcan Capital, Threshold Ventures, Tao Capital Partners and ALS Investment Fund
Bloom Science, Inc. raised $12M on December 9, 2021
Investors: Joyance Partners, Apollo Ventures, Leaps by Bayer and ALS Investment Fund
Prilenia raised $43M on November 3, 2021
Investors: Sectoral Asset Management, Amplitude Ventures, Sands Capital Management, Morningside Venture Partners, Forbion and ALS Investment Fund
Apic Bio, Inc. raised $42M on January 7, 2019
Investors: Morningside Venture Capital 晨兴资本 and ALS Investment Fund
Emulate, Inc. raised $36M on June 18, 2018
Investors: Starlight Ventures, GlassWall Syndicate, SciFi VC, Beyond Impact VC, Founders Fund and ALS Investment Fund
Orphazyme A/S raised $15M on March 8, 2017
Investors: Aescap, Novo Holdings, Idinvest Partners, Sunstone Life Science Ventures and ALS Investment Fund
Amylyx Pharmaceuticals raised $5M on August 22, 2016
Investors: Lysosomal Therapeutics Inc. and ALS Investment Fund